These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 589698)

  • 21. [Quantitative structure-activity relationship prediction of carcinogenicity of N-nitroso compounds based on category approach and read-across].
    Liang QQ; Zheng WW; He GS; Qu WD
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):621-627. PubMed ID: 28693087
    [No Abstract]   [Full Text] [Related]  

  • 22. Regiospecificity in the metabolism of the homologous cyclic nitrosamines, N'-nitrosonornicotine and N'-nitrosoanabasine.
    Hecht SS; Young R
    Carcinogenesis; 1982; 3(10):1195-9. PubMed ID: 7172419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of substituents on the carcinogenicity of n-nitrosopyrrolidine in Sprague-Dawley rats.
    Lijinsky W; Taylor HW
    Cancer Res; 1976 Jun; 36(6):1988-90. PubMed ID: 178438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Reduction of carcinogenicity of nitrosamines by photodegradation].
    Zhang ZD
    Zhonghua Zhong Liu Za Zhi; 1983 Jul; 5(4):270-3. PubMed ID: 6653343
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship of urinary N-butyl-N-(3-carboxypropyl)nitrosamine to susceptibility of animals to bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Suzuki E; Mochizuki M; Okada M
    Gan; 1983 Jun; 74(3):360-4. PubMed ID: 6884694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Becci PJ; Thompson HJ; Grubbs CJ; Moon RC
    J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573
    [No Abstract]   [Full Text] [Related]  

  • 27. Carcinogenicity of N-nitroso-3-hydroxypyrrolidine and dose-response study with N-nitrosopiperidine in rats.
    Eisenbrand G; Habs M; Schmähl D; Preussmann R
    IARC Sci Publ; 1980; (31):657-66. PubMed ID: 7228288
    [No Abstract]   [Full Text] [Related]  

  • 28. [Non-carcinogenicity of dimethyl-thionitrosamine in rats].
    Schmähl D; Krüger FW
    Z Krebsforsch; 1969; 73(2):191-2. PubMed ID: 4245383
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluoro-substituted N-nitrosamines. 5. Carcinogenicity of n-nitroso-bis-(4,4,4-trifluoro-n-butyl)amine in rats.
    Preussmann R; Habs M; Habs H; Stummeyer D
    Carcinogenesis; 1982; 3(10):1219-22. PubMed ID: 7172421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative carcinogenicity of two isomers of nitroso-2,6-dimethylmorpholine in guinea pigs.
    Lijinsky W; Reuber MD
    Cancer Lett; 1981 Oct; 14(1):7-11. PubMed ID: 7296543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carcinogenicity of N-nitroso-3,4-dichloro- and n-nitroso-3,4-dibromopiperidine in rats.
    Lijinsky W; Taylor HW
    Cancer Res; 1975 Nov; 35(11 Pt 1):3209-11. PubMed ID: 1182707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative carcinogenic effectiveness of derivatives of nitrosodiethylamine in rats.
    Lijinsky W; Taylor HW
    Cancer Res; 1978 Aug; 38(8):2391-4. PubMed ID: 667837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinogenicity of N'-nitrosonornicotine in Sprague-Dawley rats.
    Singer GM; Taylor HW
    J Natl Cancer Inst; 1976 Dec; 57(6):1275-6. PubMed ID: 1003559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinogenesis in rats by some hydroxylated acyclic nitrosamines.
    Lijinsky W; Saavedra JE; Reuber MD
    Carcinogenesis; 1984 Feb; 5(2):167-70. PubMed ID: 6697433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transplantability of urinary bladder carcinomas induced in ACI-N rats by oral administration of N-butyl-N-butanol(4)-nitrosamine and its acetate].
    Noda M; Hashimoto Y
    Nihon Hinyokika Gakkai Zasshi; 1973 May; 64(5):397-401. PubMed ID: 4738867
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinogenic effects of sequential administration of two nitrosamines in Fischer 344 rats.
    Michejda CJ; Kroeger-Koepke MB; Kovatch RM
    Cancer Res; 1986 May; 46(5):2252-6. PubMed ID: 3697969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of disulfiram on the carcinogenicity of nitrosamines.
    Schweinsberg F; Weissenberger I; Burkle V
    IARC Sci Publ; 1982; (41):649-57. PubMed ID: 7141572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carcinogenicity of N-nitrosodiethanolamine in rats at five different dose levels.
    Preussmann R; Habs M; Habs H; Schmähl D
    Cancer Res; 1982 Dec; 42(12):5167-71. PubMed ID: 7139619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response study on the carcinogenicity of N-nitrosodiethanolamine in male Sprague-Dawley rats.
    Preussmann R; Habs M; Schmähl D; Eisenbrand G
    IARC Sci Publ; 1982; (41):591-6. PubMed ID: 7141565
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.